Top compounds associated with response to RTCA


Feature Type Standardized
Nominal ANOVA
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.084 0.005
mRNA MLN2238 CTRPv2 pan-cancer AAC 0.096 0.005
mRNA fluvastatin CTRPv2 pan-cancer AAC 0.1 0.005
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.12 0.006
mRNA PD173074 GDSC1000 pan-cancer AAC -0.1 0.006
mRNA phenformin GDSC1000 pan-cancer AAC 0.088 0.006
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.006
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.006
mRNA prima-1 CTRPv2 pan-cancer AAC -0.086 0.006
mRNA CR-1-31B CTRPv2 pan-cancer AAC 0.088 0.007
Download CSV